Breaking News
Sort by:
Date
Top Post
NHS To Offer Licensed Cannabis-Based Medicine To Treat Rare Genetic Condition
The NHS will be able to prescribe cannabidiol (Cannabis) to patients with a rare, seizure-causing […]
Robocath Achieves Positive Results in R-Evolution Multicenter European Clinical Study on Robotic Coronary Angioplasty
Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of […]
Robocath Concludes First European Clinical Study to Demonstrate Safety and Efficacy of Robotic Coronary Angioplasty Performed with R-One
Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of […]
- Cardiff Oncology Announces the Appointment of Fairooz Kabbinavar, MD, FACP, as Chief Medical Officer Read more
- iCRYO Announces Partnership with Therapeutic Manufacturer, BTL Read more
- Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-MMP7 for Treatment of Idiopathic Pulmonary Fibrosis Read more
- Agomab Reports Positive Phase 1 Results with AGMB-129, a GI-restricted ALK5 Inhibitor for Fibrostenosing Crohn’s Disease Read more
- Poseida Therapeutics Announces Board Change Read more